Diego Provvedini

Title: Diego Provvedini: Innovator in Pharmaceutical Formulations

Introduction

Diego Provvedini is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for parenteral administration. His work focuses on enhancing the efficacy and stability of pharmaceutical products.

Latest Patents

Diego Provvedini holds a patent for a pharmaceutical parenteral formulation containing carglumic acid. This innovative formulation is designed for parenteral administration and includes a buffering agent with a pK from 5.5 to 9.0 at 25°C. Specifically, the buffering agent may have a pK from 7.5 to 8.5, with a preferred pK of about 8.07, such as trometamol. Additionally, the formulation may contain at least one bulking agent, such as mannitol. The invention also encompasses a method for manufacturing a lyophilized sterile formulation by freeze-drying a water solution containing carglumic acid, a buffering agent, and optionally a bulking agent to obtain a freeze-dried powder.

Career Highlights

Diego Provvedini is associated with Recordati Industria Chimica E Farmaceutica S.p.a., where he applies his expertise in pharmaceutical formulations. His work has contributed to advancements in the field, particularly in the formulation of drugs that require precise pH levels for optimal effectiveness.

Collaborations

Diego has collaborated with notable colleagues, including Pierluigi Farina and Marco Barchielli. These collaborations have fostered innovation and development in pharmaceutical research and formulation.

Conclusion

Diego Provvedini is a distinguished inventor whose work in pharmaceutical formulations has the potential to impact the industry significantly. His innovative approach to drug formulation exemplifies the importance of research and development in creating effective medical solutions.